Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119903454 | 11990345 | 4 | F | 20160115 | 20160712 | 20160202 | 20160715 | EXP | CA-BIOGEN-2016BI00181742 | BIOGEN | 52.60 | YR | F | Y | 0.00000 | 20160715 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119903454 | 11990345 | 1 | PS | FAMPYRA | DALFAMPRIDINE | 1 | Oral | 22250 | 10 | MG | PROLONGED-RELEASE TABLET | BID | |||||||
119903454 | 11990345 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119903454 | 11990345 | 1 | Gait disturbance |
119903454 | 11990345 | 2 | Multiple sclerosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119903454 | 11990345 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119903454 | 11990345 | Dysphagia | |
119903454 | 11990345 | Intervertebral disc protrusion | |
119903454 | 11990345 | Musculoskeletal disorder | |
119903454 | 11990345 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119903454 | 11990345 | 1 | 20140817 | 0 | ||
119903454 | 11990345 | 2 | 20121101 | 0 |